We describe here seven cases (from five kindreds) of Anderson's disease, which is characterized by diarrhea, steatorrhea, hypobetalipoproteinemia with low levels of cholesterol, triglycerides, and phospholipids, and failure to secrete chylomicrons after a fat meal. Enterocytes isolated from intestinal biopsies of patients after overnight fast showed numerous fat droplets, a histological picture resembling that of abetalipoproteinemia. Immunoenzymatic staining of the enterocytes demonstrated large amounts of material that reacted with a polyclonal antiserum to apolipoprotein B. Further, the immunoreactive material was found to react with several different monoclonal antibodies capable of recognizing both the B100 and B48 forms of apoprotein B, but not with any of several monoclonal antibodies capable of recognizing only B100. This suggests that the material in the enterocytes is the B48 form of apoprotein B or a fragment thereof. Additional findings included decreased low density lipoprotein levels with an abnormal chemical composition, abnormal high density lipoprotein2 (HDL2) and HDL3 particle size distributions, and an abnormal HDL apoprotein composition. Increased amounts of proteins having electrophoretic mobilities similar to apo E and the E-AII complex were present. Finally, some cases exhibited additional protein components of apparent molecular weights between 17,000 and 28,000, which was similar to some cases of abetalipoproteinemia. These findings demonstrate that Anderson's disease is not due to the absence of synthesis of intestinal apo B and suggest that it is more complex than previously thought, affecting all the lipoprotein classes.
M E Bouma, I Beucler, L P Aggerbeck, R Infante, J Schmitz
Title and authors | Publication | Year |
---|---|---|
New Classification and Management of Abetalipoproteinemia and Related Disorders
C Bredefeld, N Peretti, MM Hussain, MD Filippo, E Granot, C Cuerq, P Poinsot, P Moulin, S Charrière, M Brin, RJ Deckelbaum, DD Black |
Gastroenterology | 2021 |
Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease
C Cuerq, E Henin, L Restier, E Blond, J Drai, C Marcais, MD Filippo, C Laveille, MC Michalski, P Poinsot, C Caussy, A Sassolas, P Moulin, E Reboul, S Charriere, E Levy, A Lachaux, N Peretti |
Journal of lipid research | 2018 |
Inborn Metabolic Diseases
JM Saudubray, MR Baumgartner, J Walter |
Inborn Metabolic Diseases | 2016 |
Dyslipidemias: Pathophysiology, Evaluation and Management
A Garg |
2015 | |
Diagnosis and Management of Familial Dyslipoproteinemias
PO Kwiterovich |
Current Cardiology Reports | 2013 |
Exon Skipping of Hepatic APOB Pre-mRNA With Splice-switching Oligonucleotides Reduces LDL Cholesterol In Vivo
P Disterer, R Al-Shawi, S Ellmerich, SN Waddington, JS Owen, JP Simons, B Khoo |
Molecular Therapy | 2013 |
Inherited hematological disorders due to defects in coat protein (COP)II complex
R Russo, MR Esposito, A Iolascon |
American Journal of Hematology | 2012 |
Morson and Dawson's Gastrointestinal Pathology: Shepherd/Morson and Dawson's Gastrointestinal Pathology
I Brown |
Morson and Dawson's Gastrointestinal Pathology: Shepherd/Morson and Dawson's Gastrointestinal Pathology | 2012 |
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk
S Calandra, P Tarugi, HE Speedy, AF Dean, S Bertolini, CC Shoulders |
Journal of lipid research | 2011 |
Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease)
A Georges, J Bonneau, D Bonnefont-Rousselot, J Champigneulle, JP Rabès, M Abifadel, T Aparicio, JC Guenedet, E Bruckert, C Boileau, A Morali, M Varret, LP Aggerbeck, ME Samson-Bouma |
Orphanet Journal of Rare Diseases | 2011 |
Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene
AB Cefalù, PL Calvo, D Noto, M Baldi, V Valenti, P Lerro, F Tramuto, A Lezo, I Morra, G Cenacchi, C Barbera, MR Averna |
Metabolism | 2010 |
Sleisenger and Fordtran's Gastrointestinal and Liver Disease
C Högenauer, HF Hammer |
Sleisenger and Fordtran's Gastrointestinal and Liver Disease | 2010 |
The Biogenesis of Chylomicrons
CM Mansbach, SA Siddiqi |
Annual Review of Physiology | 2010 |
Formes rares de dyslipidémies génétiques
G Luc |
EMC - Endocrinologie - Nutrition | 2010 |
The mechanism of the formation and secretion of chylomicrons
T Kindel, DM Lee, P Tso |
Atherosclerosis Supplements | 2010 |
Les dyslipidémies héréditaires
P Couvert, P Giral, D Bonnefont-Rousselot, A Carrié |
Revue Francophone des Laboratoires | 2010 |
Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers
N Peretti, A Sassolas, CC Roy, C Deslandres, M Charcosset, J Castagnetti, L Pugnet-Chardon, P Moulin, S Labarge, L Bouthillier, A Lachaux, E Levy |
Orphanet Journal of Rare Diseases | 2010 |
Chylomicron retention disease: A long term study of two cohorts
N Peretti, CC Roy, A Sassolas, C Deslandres, E Drouin, A Rasquin, E Seidman, P Brochu, MC Vohl, S Labarge, R Bouvier, ME Samson-Bouma, M Charcosset, A Lachaux, E Levy |
Molecular Genetics and Metabolism | 2009 |
Hypocholestérolémies génétiques : abêtalipoprotéinémie, hypobêtalipoprotéinémie familiale, maladie d'Anderson
ME Samson-Bouma, N Berriot-Varoqueaux, T Aparicio, J Schmitz, LP Aggerbeck |
EMC - Gastro-entérologie | 2009 |
Reply
J Bommer, T Heinrich, H Heidt, V Hafner, E Jenetzky, I Walter-Sack, G Mikus |
Nephrology Dialysis Transplantation | 2008 |
Anderson or chylomicron retention disease: Molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein
M Charcosset, A Sassolas, N Peretti, CC Roy, C Deslandres, D Sinnett, E Levy, A Lachaux |
Molecular Genetics and Metabolism | 2008 |
Anderson’s disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities
M Silvain, D Bligny, T Aparicio, P Laforêt, A Grodet, N Peretti, D Ménard, F Djouadi, C Jardel, JM Bégué, F Walker, J Schmitz, A Lachaux, LP Aggerbeck, ME Samson-Bouma |
Clinical Genetics | 2008 |
Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes
S Guilmeau, I Niot, JP Laigneau, H Devaud, V Petit, N Brousse, R Bouvier, L Ferkdadji, C Besmond, LP Aggerbeck, A Bado, ME Samson-Bouma |
Histochemistry and Cell Biology | 2007 |
Pediatric Endocrinology
PS Thornton |
Pediatric Endocrinology | 2005 |
Encyclopedia of Endocrine Diseases
J Borén, O Wiklund |
Encyclopedia of Endocrine Diseases | 2004 |
The intracellular transport of chylomicrons requires the small GTPase, Sar1b:
CC Shoulders, DJ Stephens, B Jones |
Current Opinion in Lipidology | 2004 |
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders
B Jones, EL Jones, SA Bonney, HN Patel, AR Mensenkamp, S Eichenbaum-Voline, M Rudling, U Myrdal, G Annesi, S Naik, N Meadows, A Quattrone, SA Islam, RP Naoumova, B Angelin, R Infante, E Levy, CC Roy, PS Freemont, J Scott, CC Shoulders |
Nature Genetics | 2003 |
Chylomicron Retention Disease
R Boldrini, R Biselli, C Bosman |
Pathology - Research and Practice | 2001 |
A proposed model for the assembly of chylomicrons
MM Hussain |
Atherosclerosis | 2000 |
Pediatric Gastrointestinal Mucosal Biopsy: Special Considerations in Children
P Gillett, E Hassall |
Gastrointestinal Endoscopy Clinics of North America | 2000 |
Chinese hamster ovary cells require the coexpression of microsomal triglyceride transfer protein and cholesterol 7alpha-hydroxylase for the assembly and secretion of apolipoprotein B-containing lipoproteins
JF Fleming, GM Spitsen, TY Hui, L Olivier, EZ Du, M Raabe, RA Davis |
The Journal of biological chemistry | 1999 |
Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver
RA Davis |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 1999 |
Anderson’s Disease: Exclusion of Apolipoprotein and Intracellular Lipid Transport Genes
AH Dannoura, N Berriot-Varoqueaux, P Amati, V Abadie, N Verthier, J Schmitz, JR Wetterau, ME Samson-Bouma, LP Aggerbeck |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Human Apolipoprotein B RNA Editing Deaminase Gene (APOBEC1)
T Fujino, N Navaratnam, J Scott |
Genomics | 1998 |
Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoproteinemic kindred without any ApoB truncation
JI Pulai, M Averna, RA Srivastava, MA Latour, RE Clouse, RE Ostlund, G Schonfeld |
Metabolism | 1997 |
Studies on lipoprotein metabolism in a family with jejunal chylomicron retention
A Nemeth, U Myrdal, B Veress, M Rudling, L Berglund, B Angelin |
European Journal of Clinical Investigation | 1995 |
Chylomicron retention disease: exclusion of apolipoprotein B gene defects and detection of mRNA editing in an affected family
S Patel, M Pessah, I Beucler, J Navarro, R Infante |
Atherosclerosis | 1994 |
Postprandial lipemia in subjects with hypobetalipoproteinemia and a single intestinal allele for apoB-48
M Averna, RL Seip, K Mankowitz, G Schonfeld |
Journal of lipid research | 1993 |
Case 35-1992 : An Eight-Month-Old Boy with Diarrhea and Failure to Thrive
RC Cabot, RE Scully, EJ Mark, WF McNeely, BU McNeely |
New England Journal of Medicine | 1992 |
Case 35-1992: An Eight-Month-Old Boy with Diarrhea and Failure to Thrive
RC Cabot, RE Scully, EJ Mark, WF McNeely, BU McNeely |
New England Journal of Medicine | 1992 |
Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia
JR Wetterau, LP Aggerbeck, ME Bouma, C Eisenberg, A Munck, M Hermier, J Schmitz, G Gay, DJ Rader, RE Gregg |
Science | 1992 |
Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families
M Pessah, P Benlian, I Beucler, N Loux, J Schmitz, C Junien, R Infante |
Journal of Clinical Investigation | 1991 |
A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene
S Fazio, A Sidoli, A Vivenzio, A Maietta, S Giampaoli, A Menotti, R Antonini, G Urbinati, FE Baralle, G Ricci |
Journal of Internal Medicine | 1991 |
Clinical chemistry
DJ Anderson, FV Lente, FS Apple, SC Kazmierczak, JA Lott, MK Gupta, N McBride, WE Katzin, RE Scott, al. |
Analytical Chemistry | 1991 |
The genetic dyslipoproteinemias — nosology update 1990
G Schonfeld |
Atherosclerosis | 1990 |
L'hypobêtalipoprotéinémie familiale Étude familiale de 4 cas
G Gay, M Pessah, ME Bouma, JF Roche, JP Aymard, I Beucler, LP Aggerbeck, R Infante |
La Revue de Médecine Interne | 1990 |
Inherited Disorders of Lipid Transport
G Schonfeld |
Endocrinology and metabolism clinics of North America | 1990 |
Enhanced clearance from plasma of low density lipoproteins containing a truncated apolipoprotein, apoB-89
KG Parhofer, A Daugherty, M Kinoshita, G Schonfeld |
Journal of lipid research | 1990 |
Description of two different patients with abetalipoproteinemia: synthesis of a normal-sized apolipoprotein B-48 in intestinal organ culture
ME Bouma, I Beucler, M Pessah, C Heinzmann, AJ Lusis, HY Naim, T Ducastelle, B Leluyer, J Schmitz, R Infante |
Journal of lipid research | 1990 |
Apolipoprotein B-100: immunolocalization and synthesis in human intestinal mucosa
E Levy, C Rochette, I Londono, CC Roy, RW Milne, YL Marcel, M Bendayan |
Journal of lipid research | 1990 |
Biosynthetic precursor (214 kDa) of apolipoprotein B-48 is not secreted by Caco-2 cells and normal human intestine
WV Sasak, HA Buller, R Reinhold |
Biochemical Journal | 1989 |
Rat intestinal apolipoprotein B gene expression. Evidence for integrated regulation by bile salt, fatty acid, and phospholipid flux
NO Davidson, MJ Drewek, JI Gordon, J Elovson |
Journal of Clinical Investigation | 1988 |
Immunoperoxidase Localization of Apolipoprotein D in Human Enterocytes and Hepatocytes
ME Bouma, JP Bandt, M Ayrault-Jarrier, J Burdin, N Verthier, A Raisonnier |
Scandinavian Journal of Gastroenterology | 1988 |
Steatorrhea and Disorders of Chylomicron Synthesis and Secretion
E Levy, JP Chouraqui, CC Roy |
Pediatric Clinics of North America | 1988 |
Chylomicron retention disease
ME Bouma, R Infante, J Jos, J Schmitz |
Gastroenterology | 1988 |
Genetic factors affecting blood lipoproteins: the candidate gene approach
AJ Lusis |
Journal of lipid research | 1988 |
Biosynthetic relationships between three rat apolipoprotein B peptides
MA Reuben, KL Svenson, MH Doolittle, DF Johnson, AJ Lusis, J Elovson |
Journal of lipid research | 1988 |
Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility
RA Hegele, JL Breslow, CR Cloninger |
Genetic Epidemiology | 1987 |
Hypobêtalipoprotéinémie: aspect endoscopique - intérêt diagnostique
G Gay, JF Roche, P Merlin, J GrÉGoire |
Acta Endoscopica | 1987 |
Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease
E Levy, Y Marcel, RJ Deckelbaum, R Milne, G Lepage, E Seidman, M Bendayan, CC Roy |
Journal of lipid research | 1987 |